Plenary Session - Thursday
Thursday, October 14, 2021 |
8:55 AM - 10:30 AM |
Speaker
Questions & Discussion
Questions & Discussion
9:40 AM - 10:00 AMBiography
Dr Niklas Luhmann
Technical Officer
WHO
Real-world progress on hepatitis C elimination and future implementation challenges: Implications for people who inject drugs
9:00 AM - 9:20 AMBiography
Dr Niklas Luhmann is a medical doctor with a Masters in International Public Health. He has been working for more than 10 years on access to healthcare with a focus on HIV and viral hepatitis. He joined WHO in 2019 where he works as a technical officer and leads the viral hepatitis prevention, testing and populations work.
Dr. Stacey Trooskin
Chief Medical Officer
Philadelphia Fight Community Health Centers
Interventions to enhance testing and linkage to treatment for hepatitis C infection
9:20 AM - 9:40 AMBiography
Stacey Trooskin, MD, PhD is Chief Medical Officer and Director of Viral Hepatitis Programs at Philadelphia FIGHT Community Health Centers and is a faculty member of the Infectious Diseases Division at the University of Pennsylvania, Perelman School of Medicine.
Dr Christopher Byrne
Public Health Intelligence Adviser
Public Health Scotland
Reaching people receiving opioid agonist therapy attending community pharmacies with HCV: An international cluster randomised controlled trial.
10:00 AM - 10:15 AMBiography
Christopher Byrne is a Clinical Trial Coordinator and PhD candidate at University of Dundee, his work focuses on hepatitis c virus infection.
Mr. Trevor Goodyear
PhD Student
University Of British Columbia
“Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs
10:15 AM - 10:30 AMBiography
Trevor Goodyear is a registered nurse and PhD student in the School of Nursing, University of British Columbia. He is also an Addiction Medicine Research Fellow with the British Columbia Centre on Substance Use. Trevor uses critical qualitative research approaches to advance health equity with people who use drugs.
Chair
Behzad Hajarizadeh
Associate Professor
Unsw / Kirby Institute
Lise Lafferty
Senior Research Fellow
Centre for Social Research in Health
Speaker - will not appear in Portal
Christopher Byrne
Public Health Intelligence Adviser
Public Health Scotland
Trevor Goodyear
PhD Student
University Of British Columbia
Margaret Hellard
Deputy Director
Burnet Institute
Niklas Luhmann
Technical Officer
WHO
Stacey Trooskin
Chief Medical Officer
Philadelphia Fight Community Health Centers
